Track Merit Medical Systems, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Merit Medical Systems, Inc. MMSI · Stock Open Merit Medical Systems, Inc. in new tab

86.63 USD
P/E
32.85
EPS
2.67
P/B
3.01
ROE
9.78
Beta
0.55
Target Price
107.00 USD
Merit Medical Systems, Inc. logo

Merit Medical Systems, Inc.

🧾 Earnings Recap – Q1 2026

Shares dropped 9% following Merit Medical’s Q1 report, reflecting investor disappointment with the cautious outlook and updated guidance despite solid top-line growth and margin improvement.

  • Q1 revenue rose 7% GAAP and 5% constant currency to $381.9 million, driven by 2.7% organic growth plus acquisition contributions.
  • Non-GAAP operating margin increased 47 basis points to a record first-quarter 19.7%.
  • Non-GAAP EPS grew 9%, and free cash flow increased 26% year-over-year to $25 million.
  • Guidance was updated to incorporate View Point Medical acquisition impacts, suggesting a more cautious outlook.
  • Strategic initiatives included the commercial launch of the Resilience TTS Esophageal Stent and expansion of the oncology portfolio through the $140 million View Point Medical acquisition.
📅
Loading chart...
Key Metrics
Earnings dateFeb. 24, 2027
P/E32.85
EPS2.67
Book Value29.13
Price to Book3.01
Debt/Equity47.12
% Insiders2.438%
Growth
Revenue Growth0.08%
Earnings Growth0.52%
Estimates
Forward P/E18.79
Forward EPS4.67
Target Mean Price107.00

DCF valuation

Model fair value for Merit Medical Systems, Inc. (MMSI)
Result
Sign in to run the valuation for MMSI.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
12 analysts · consensus Buy · mean target 107.00 USD (low 90.00, high 123.00) · as of 11 Nov 2026
Low 90.00
Mean 107.00
High 123.00
Price 86.63
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Merit Medical Systems, Inc. Logo Merit Medical Systems, Inc. Analysis (MMSI)

United States Health Care Official Website Stock

Is Merit Medical Systems, Inc. a good investment? Merit Medical Systems, Inc. (MMSI) is currently trading at 86.63 USD. Market analysts have a consensus price target of 107.00 USD. This suggests a potential upside from current levels.

In terms of valuation, the stock trades at a P/E ratio of 32.85. This high multiple suggests investors have priced in significant future growth expectations.

Earnings Schedule: Merit Medical Systems, Inc. is expected to release its next earnings report on Feb. 24, 2027. The market consensus estimate for Forward EPS is 4.67.

Investor FAQ

Does Merit Medical Systems, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Merit Medical Systems, Inc.?

Merit Medical Systems, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Feb. 24, 2027. The company currently has a trailing EPS of 2.67.

Company Profile

Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally. It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; kits and accessories for endoscopy and bronchoscopy procedures; and temporary pacing technology. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. The company was incorporated in 1987 and is headquartered in South Jordan, Utah.

Exchange Ticker
FRA (Germany) MM3.F
NMS (United States) MMSI
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
July 16, 1991 1.5
Aug. 28, 2001 1.25
April 12, 2002 1.25
Aug. 15, 2003 1.33
Dec. 3, 2003 1.33
May 6, 2011 1.25
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion